Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S29 pseudogene 2 (RPS29P2) is a processed pseudogene of the ribosomal protein S29 gene. Pseudogenes are non-functional DNA segments that resemble functional genes but typically lack coding potential and are not translated into functional proteins. RPS29P2 does not produce a functional protein and has no known direct biological or disease-related role[2][5][6][8]. Unlike the functional RPS29 gene, which is involved in ribosome assembly and is disease-associated, RPS29P2 appears to be a genomic remnant with no evidence for protein coding, function, druggability, or clinical impact[2][7][8]. Key details: - The canonical gene encoding the functional protein is RPS29 (ribosomal protein S29), not RPS29P2. - RPS29P2 is not a therapeutic target, receptor, enzyme, transporter, or transcription factor. - There are no drugs targeting this pseudogene, nor any known mechanisms of action, biomarkers, or safety concerns related to it[2][5][6][8]. If you are seeking information on the functional ribosomal protein S29, see RPS29, not RPS29P2[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S29 pseudogene 2 (RPS29P2).